Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 Jan 28;6(3):303–311. doi: 10.1111/j.1750-3639.1996.tb00857.x

Animal Models of Demyelination

M Bradl 1, C Linington 1,✉
PMCID: PMC7161775  PMID: 8864286

Abstract

Demyelination is a pathological feature that is characteristic of many diseases of the central nervous system (CNS) including multiple sclerosis (MS), sub‐acute sclerosing panencephalomyelitis (SSPE), metachromatic leukodystrophy and Pelizaeus‐Merzbacher disease. While demyelination is a pathological end‐point that is common to all of these diseases, the cellular and molecular mechanisms responsible for this pathology are very different. These range from genetic defects that affect lipid metabolism in the leukodystrophies, cytopathic effects of viral infection in SSPE to the action of immunological effector mechanisms in MS and the viral encephalopathies. Irrespective of the initial cause of myelin degradation, many of these disorders are associated with some degree of CNS inflammation, as indicated by the local activation of microglia, recruitment of macrophages or the intrathecal synthesis of immunoglobulin. Many of these phenomena are now being duplicated in animal models, providing not only new insights into the pathogenesis of human demyelinating diseases, but also unexpected interrelationships between the immune response in the CNS and the pathogenesis of diseases such as Alzheimers disease and HIV encephalopathy. Autoimmune mediated models of inflammatory demyelinating CNS disease have proved particularly valuable in this respect as they allow the effects of defined immune effector mechanisms to be studied in the absence of CNS infection.

References

  • 1. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu J‐M, Gardinier MV, Dornmair K, Linington C. (1995) The N‐terminal domain of the myelin oligodoendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63: 17–27. [DOI] [PubMed] [Google Scholar]
  • 2. Amiguet P, Gardinier MV, Zanetta J‐P, Matthieu J‐M (1992) Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein. J Neurochem 58: 1676–1682. [DOI] [PubMed] [Google Scholar]
  • 3. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu J‐M, Baker D (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153: 4349–4356. [PubMed] [Google Scholar]
  • 4. Bernheimer H, Budka H, Muller P (1983) Brain tissue immunoglobulins in adrenoleukodystrophy: a comparison with multiple sclerosis and systemic lupus erythematosis. Acta Neuropathol 59: 95–102. [DOI] [PubMed] [Google Scholar]
  • 5. Boison D, Stoffel W (1994) Disruption of the compacted myelin sheath of axons of the central newous system in proteolipid protein‐deficient mice. Proc Natl Acad Sci USA 91:11709–11713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Breder CD, Tsujimoto M, Teranot Y, Scott DW, Saper CB (1993) Distribution and characterization of tumor necrosis factor like immunoreactivity in the murine central nervous system. J Comp Neurol 337: 543–567. [DOI] [PubMed] [Google Scholar]
  • 7. Brunner C, Lassmann H, Waehneldt TV, Matthieu J‐M, Linington C (1989) Differential ultrastructural localization of myelin basic protein, myelin/oligodendrocyte glycoprotein, and 2′,3′‐cyclic nucleotide 3′‐phosphodiesterase in the CNS of adult rats. J Neurochem 52:296–304. [DOI] [PubMed] [Google Scholar]
  • 8. Chiang C‐S, Powell HC, Gold LH, Samimi A, Campbell IL (1996) Macrophage/microgliaI‐mediated primary demyelination and motor disease induced by the central nervous system production of Interleukin‐3 in transgenic mice. J Clin Invest 97: 1512–1524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Carango P, Funanage VL, Quiros RE, Debruyn CS, Marks HG (1995) Overexpression of DM20 messenger RNA in two brothers with Pelizaeus‐Merzbacher disease. Ann Neurol 38: 610–617. [DOI] [PubMed] [Google Scholar]
  • 10. Dal Canto MC, Lipton HL (1975): Primary demyelination in Theiler's virus infection: An ultrastructural study. Lab Invest 33: 626–637. [PubMed] [Google Scholar]
  • 11. Gardinier MV, Amiguet P, Linington C, Matthieu J‐M (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neuroscr Res 33:177–187. [DOI] [PubMed] [Google Scholar]
  • 12. Griffin DE, Moser HW, Mendoza Q, Moench TR, O'Toole S, Moser AB (1985) Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy. Ann Neurol 18: 660–664. [DOI] [PubMed] [Google Scholar]
  • 13. Hodes ME, DeMyer WE, Pratt VM, Edwards MK, Dlouhy SR (1995) Girl with signs of Pelizaeus‐Merzbacher disease heterozygous for a mutation in exon 2 of the proteolipid protein gene. Am J Med Genet 55: 397–401. [DOI] [PubMed] [Google Scholar]
  • 14. Huitinga I, Ruuls SR, Jung S, Van Rooijen N, Hartung H‐P, Dijkstra CD (1995) Macrophages in T cell line mediated, demyelinating, and chronic‐relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin Exp Immunol 100:344–351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Igarashi M, Schaumburg HH, Powers J, Kishimoto Y, Kolodny E, Suzuki K (1976) Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26: 851–860. [DOI] [PubMed] [Google Scholar]
  • 16. Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales ME Bernard CCA (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 154: 5536–5541. [PubMed] [Google Scholar]
  • 17. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13: 427–442. [DOI] [PubMed] [Google Scholar]
  • 18. Kerlero de Rosbo N, Mendel I, Ben‐Nun A (1995) Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical course, induced on PL/J mice by myelin oligodendrocyte glycoprotein (MOGI‐derived peptide: Preliminary analysis of MOG T cell epitopes. Eur J Immunol 25: 985–993. [DOI] [PubMed] [Google Scholar]
  • 19. Kerner A‐L, Carson JH (1984) Effect of the jimpy mutation on expression of myelin proteins in heterozygous and hemizygous mouse brain. J Neurochem 43: 1706–1715. [DOI] [PubMed] [Google Scholar]
  • 20. Kleindorfer DO, Dlouhy SR, Pratt VM, Jones MC, Trofatter JA, Hodes ME (1995) In‐frame deletion in the proteolipid protein gene of a family with Pelizaeus‐Merzbacher disease. Am J. Med Genet 55: 405–407. [DOI] [PubMed] [Google Scholar]
  • 21. Koeppen AH, Barron KD, Czisa CK, Greenfield EA (1988) Comparative immunochemistry of Pelizaeus‐Merzbacher disease, the jimpy mouse, and the myelin‐deficient rat. J Neurol Sci 84: 315–327. [DOI] [PubMed] [Google Scholar]
  • 22. Kurosawa K, Twaki A, Miyake S, Imaizumi K, Kuroki Y, Fukumaki Y (1993) A novel insertional mutation at exon VII of the myelin proteolipid protein gene in Pelizaeus‐Merzbacher disease. Hum Mol Gen 2: 2187–2189. [DOI] [PubMed] [Google Scholar]
  • 23. Lambracht D, Prokop C, Hedrich HJ, Fischer Lindahl K, Wonigeit K (1995) Mapping of H2‐M homolog and MOG genes in the rat MHC. Immonogenetics 42:418–421. [DOI] [PubMed] [Google Scholar]
  • 24. Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuroparhol 75: 566–576. [DOI] [PubMed] [Google Scholar]
  • 25. Lebar A, Lubetzki C, Vincent C, Lombrail P, Poutry J‐M (1986) The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membranes. Clin Exp Immunol 66: 432–443. [PMC free article] [PubMed] [Google Scholar]
  • 26. Linington C, Berger T, Perry L, Weerth S, Hinze‐Selch D, Zhang Y, Lu H‐C, Lassmann H, Wekerle H (1993) T cells specific for the myelin oligodendrocyte glycoprotein (MOG) mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23: 1364–1372. [DOI] [PubMed] [Google Scholar]
  • 27. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130: 443–454. [PMC free article] [PubMed] [Google Scholar]
  • 28. Linington C, Lassmann H (1987) Antibody responses in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with anti body titer to myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 17: 61–70. [DOI] [PubMed] [Google Scholar]
  • 29. Linington C, Webb M, Woodhams PL (1984) A novel myelin‐associated glycoprotein defined by a mouse mon oclonal antibody. J Neurojmmunol 6: 387–396. [DOI] [PubMed] [Google Scholar]
  • 30. Macklin WB, Gardinier MV, King KD, Kampf K (1987) An AG‐GG transition at a splice site in the myelin proteolipid protein gene in jimpy mice results in the removal of an exon. FEBS Lett 223: 417–421. [DOI] [PubMed] [Google Scholar]
  • 31. Mastronardi F, Ackerley C, Arsenault L, Roots B, and Moscarello M (1993). Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res 36:315–324. [DOI] [PubMed] [Google Scholar]
  • 32. Mendel I, Kerlero de Rosbo N, Ben‐Nun A (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vb expression of encephalitogenic T cells. Eur J Immunol 25: 1951–1959. [DOI] [PubMed] [Google Scholar]
  • 33. Merril JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151: 2132–2141. [PubMed] [Google Scholar]
  • 34. Merzbacher L (1910) Eine eigenartige familiar‐hereditare Erkrankungsform (Aplasia axialis extracorticalis congenita). Zeitschr Ges Neurol Psychiat 3:1–138. [Google Scholar]
  • 35. Miller DJ, Asakura K, Rodriguez M (1995) Experimental strategies to promote central nervous system remyelination in multiple sclerosis: Insights gained from Theiler's virus model system. J Neurosci Res 41: 291–296. [DOI] [PubMed] [Google Scholar]
  • 36. Mosser J, Douar A‐M, Sarde C‐O, Kioschis P, Feil R, Moser H, Poustka A‐M, Mandel J‐L, Aubourg P (1993) Putative X‐linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361: 726–730. [DOI] [PubMed] [Google Scholar]
  • 37. Nave K‐A, Bloom FE, Milner RJ (1987) A single nucleotide difference in the gene for myelin proteolipid protein defines the jimpy mutation in mouse. J Neurochem 49: 1873–1877. [DOI] [PubMed] [Google Scholar]
  • 38. Nave K‐A, Lai C, Bloom FE, Milner RJ (1986) Jimpy mutant mouse: a 74 bp deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc NatlAcad Sci USA 83: 9264–9268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Pelizaeus F (1885) Uber eine eigenthumliche Form spastischer Lahmung mit Cerebralerscheinungen aufhereditarer Grundlage (Multiple Sklerose). Arch Psychiat Nervenkrankh 16: 689–710. [Google Scholar]
  • 40. Peunova N, Enikolopov G (1995) Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375: 68–73. [DOI] [PubMed] [Google Scholar]
  • 41. Pfeiffer SE, Warrington AE, Bansal R (1993) The oligodendrocyte and its many cellular processes. Trends Cell Biol 3: 191–197. [DOI] [PubMed] [Google Scholar]
  • 42. Pham‐Dinh D, Mattei M‐G, Nussbaum J‐L, Roussel G, Pontarotti P, Roeckel N, Mather IH, Artzt K, Fischer Lindahl K, Dautigny A (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci USA 90: 7990–7994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Piddlesden S, Lassmann H, Laffafian I, Morgan BP, Linington C (1991) Antibody‐mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clin Exp Immunol 83: 245–250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Piddlesden SJ, Storch MK, Hibbs M, Freeman AM, Lassmann H, Morgan BP (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody‐mediated demyelinating experimental allergic encephalomyelitis. J Immunol 152: 5477–5484. [PubMed] [Google Scholar]
  • 45. Powers JM (1985) Adreno‐leukodystrophy (adreno‐testiculo‐leuko‐myelo‐neuropathic complex). Clin Neuropathol 4: 181–199. [PubMed] [Google Scholar]
  • 46. Powers JM, Liu Y, Moser AB, Moser HW (1992) The inflammatory myelinopathy of adreno‐leukodystrophy: Celts, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 51: 630–643. [DOI] [PubMed] [Google Scholar]
  • 47. Powers JM, Schaumburg HH, Johnson AB, Raine CS (1980) A correlative study of the adrenal cortex in adreno‐leukodystrophy. Evidence for a fatal intoxication with very long chain saturated fatty acids. Invest Cell Pathol 3: 353–376. [PubMed] [Google Scholar]
  • 48. Pratt VM, Boyadjiev S, Dlouhy SR, Silver K, Der Kaloustian VM, Hodes ME (1995) Pelizaeus‐Merzbacher disease in a family of Portugese origin caused by a point mutation in exon 5 of the proteolipid protein gene. Am J Med Genet 55: 402–404. [DOI] [PubMed] [Google Scholar]
  • 49. Pratt VM, Boyadjiev S, Green K, Hodes ME, Dlouhy SR (1995) Pelizaeus‐Merzbacher disease caused by a denovo mutation that originated in exon 2 of the maternal great‐grandfather of the propositus. Am J Med Genet 58:70–73. [DOI] [PubMed] [Google Scholar]
  • 50. Pratt VM, Dlouhy SR, Hodes ME (1995) Pelizaeus‐Merzbacher disease: a point mutation in exon 6 of the proteolipid protein (PLP) gene. Clin Genet 47: 99–100. [DOI] [PubMed] [Google Scholar]
  • 51. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system‐specific expression of tumor necrosis factor α. Proc Natl Acad Sci USA 92: 11294–11298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Raine CS (1978) Membrane specializations between demyelinated axons and astroglia in chronic EAE lesions and multiple sclerosis plaques. Nature 275: 326–327. [DOI] [PubMed] [Google Scholar]
  • 53. Raine CS, Scheinberg LC, Waltz JM (1981) Multiple scle rosis: Oligodendrocyte survival and proliferation of an active, established lesion. Lab Invest 45: 534–546. [PubMed] [Google Scholar]
  • 54. Readhead C, Schneider A, Griffiths I, and Nave K‐A (1994) Premature arrest of myelin formation in transgenic mice with increased proteolipid protein genedosage. Neuron 12: 583–595. [DOI] [PubMed] [Google Scholar]
  • 55. Robbins DS, Shirzai Y, Drysdale BE, Lieberman A, Shin HS, Shin ML (1987) Production of a cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139: 2593–2597. [PubMed] [Google Scholar]
  • 56. Rodriguez M, Lindsley MD (1992) Immunosuppression promotes CNS remyelination in chronic virus‐induced demyelinating disease. Neurology 42: 348–357. [DOI] [PubMed] [Google Scholar]
  • 57. Rodriguez M, Oleszak E, Leibowitz J (1987) Theiler's murine encephalomyelitis virus: A model of demyelination and viral persistence. CRC Crit Rev Immunol 7: 325–365. [PubMed] [Google Scholar]
  • 58. Roth M‐P, Dolbois L, Borot N, Pontarotti P, Clanet M, Coppin H (1995) Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: No evidence of disease association with MOG. J Neuroimmunol 61:117–122. [DOI] [PubMed] [Google Scholar]
  • 59. Saugier‐Veber P, Munnich A, Bonneau D, Rozet J‐M, Le Merrer M, Gil R, Boespflug‐Tanguy O (1994) X‐linked spastic paraplegia and Pelizaeus‐Merzbacher disease are allelic disorders at the proteolipid protein locus. Nature Genetics 6: 257–262. [DOI] [PubMed] [Google Scholar]
  • 60. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP (1975) Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 33: 577–591. [DOI] [PubMed] [Google Scholar]
  • 61. Schneider A, Griffiths IR, Readhead C, Nave K‐A (1995) Dominant‐negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc Natl Acad Sci USA 92: 4447–4451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Segal AH, Griffin DE, Moser AB, Moser HW, Ubol S (1989) Immunological and biochemical comparison of childhood adrenoleukodystrophy (ALD) and adreno‐myeloneuropathy (AMN). Neurology 39(Suppl 1): 369–370. [Google Scholar]
  • 63. Selrnaj K, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339–346. [DOI] [PubMed] [Google Scholar]
  • 64. Selrnaj K, Raine CS, Farooq M, Norton WR, Brosnan CF (1991) Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J Immunol 147:1522–1529. [PubMed] [Google Scholar]
  • 65. Simons Johnson R, Roder JC, Riordan JR (1995) Over‐expression of the DM‐20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J Neurochem 64:967–976. [DOI] [PubMed] [Google Scholar]
  • 66. Singh I, Moser AB, Moser HW, Kishimoto Y (1984). Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts and amniocytes. Pediatr Res 18: 286–290. [DOI] [PubMed] [Google Scholar]
  • 67. Smith ME, Sornera FP, Eng LF (1983) Immunocytochemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal proteins in experimental allergic encephalomyelitis. Brain Res 246:241–253. [DOI] [PubMed] [Google Scholar]
  • 68. Sun J, Link H, Olsson H, Xiao S, Anderson G, Ekre H‐P, Linington C, Diener P (1991) T and B cell responses to myelin‐oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 146: 1490–1495. [PubMed] [Google Scholar]
  • 69. Swanborg RH (1995) Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 77:4–13. [DOI] [PubMed] [Google Scholar]
  • 70. Theda C, Moser AB, Powers JM, Moser HW (1992) Phospholipids in X‐linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. J Neurol Sci 110: 195–204. [DOI] [PubMed] [Google Scholar]
  • 71. Tosic M, Dolivo M, Domanska‐Janik K, Matthieu JM (1994) Myelin proteolipid protein mutation in the rabbit: a new model of Pelizaeus‐Merzbacher disease. Schweiz Arch Neural Psych 145: 24–26. [PubMed] [Google Scholar]
  • 72. Vassalli P. (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411–452. [DOI] [PubMed] [Google Scholar]
  • 73. Watanabe R, Wege H, Ter Meulen V (1983) Adoptive transfer of EAE‐like lesions from rats with coronavirus‐induced demyelinating encephalomyelitis. Nature 305:150–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Wekerle H, Kojima K, Lames‐Vieira J, Lassmann H, Linington C Animal models. (1994) Ann Neurol 36: S47–S53. [DOI] [PubMed] [Google Scholar]
  • 75. Yarnada M, Zurbriggen A, Fujinami RS. (1990) Monoclonai antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligoden‐drocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med 171:1893–1908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Yanagisawa K, Duncan ID, Harnmang JP, Quarles RH (1986) Myelin‐deficient rat: analysis of myelin proteins. J Neurochem 47: 1901–1907. [DOI] [PubMed] [Google Scholar]
  • 77. Yanagisawa K, Moller JR, Duncan ID, Quarles RH (1987) Disproportional expression of proteolipid protein and DM 20 in the X‐linked, dysmyelinating shaking pup. J Neurochem 49: 1912–1917. [DOI] [PubMed] [Google Scholar]
  • 78. Zimprich F, Winter J, Wege H, Lassmann H (1991) Coronavirus induced primary demyelination: Indications for the involvement of a humoral immune response. Neuropathol Appl Neurobiol 17: 469–474. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Brain Pathology (Zurich, Switzerland) are provided here courtesy of Wiley

RESOURCES